Role of L-ficolin/mannose-binding lectin-associated serine protease complexes in the opsonophagocytosis of type III group B streptococci

Journal of Immunology

Volumn 174, Issue 1, 2005, Pages 418-425

  Aoyagi, Youko ^a   Adderson, Elisabeth E ^b   Min, Jin G ^c   Matsushita, Misao ^c   Fujita, Teizo ^d   Takahashi, Shinji ^a   Okuwaki, Yoshiyuki ^a   Bohnsack, John F ^e  

^a Joshi Eiyoh University   (Japan)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c TOKAI UNIVERSITY   (Japan)

^d FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^e UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CALCIUM; CAPSULAR POLYSACCHARIDE; CLASSICAL COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT COMPONENT C4 BINDING PROTEIN; EGTAZIC ACID; FICOLIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G2; MAGNESIUM; N ACETYLGLUCOSAMINE; OPSONIN; PROTEIN; PROTEIN FICOLIN MANNOSE BINDING LECTIN ASSOCIATED SERINE PROTEASE; SERINE PROTEINASE; SIALIC ACID; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL INFECTION; BACTERICIDAL ACTIVITY; COMPLEMENT ACTIVATION; COMPLEMENT LECTIN PATHWAY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; INFECTION SENSITIVITY; MENINGITIS; NEWBORN SEPSIS; NONHUMAN; NORMAL HUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; PROTEIN PURIFICATION; SEROTYPE; STREPTOCOCCUS AGALACTIAE;

EID: 10844272309     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.1.418     Document Type: Article

References (54)

1. Baker, C. J. 2000. Group B streptococcal infections. In Streptococcal Infections: Clinical Aspects, Microbiology, and Molecular Pathogenesis. D. L. Stevens and E. L. Kaplan, eds. Oxford Univ. Press, New York, p. 222.
2. Baker, C. J., and D. L. Kasper. 1976. Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection. N. Engl. J. Med. 294:753.
3. Edwards, M. S., D. L. Kasper, H. J. Jennings, C. J. Baker, and A. Nicholson-Weller. 1982. Capsular sialic acid prevents activation of the alternative complement pathway by type III, group B streptococci. J. Immunol. 128:1278.
4. Edwards, M. S., C. J. Baker, and D. L. Kasper. 1979. Opsonic specificity of human antibody to the type III polysaccharide of group B streptococcus. J. Infect. Dis. 140:1004.
5. Edwards, M. S., A. Nicholson-Weller, C. J. Baker, and D. L. Kasper. 1980. The role of specific antibody in alternative complement pathway-mediated opsonophagocytosis of type III, group B streptococcus. J. Exp. Med. 151:1275.
6. Takahashi, S., Y. Aoyagi, E. E. Adderson, Y. Okuwaki, and J. F. Bohnsack. 1999. Capsular sialic acid limits C5a production on type III group B streptococci. Infect. Immun. 67:1866.
7. Wessels, M. R., P. Butko, M. Ma, H. B. Warren, A. L. Lage, and M. C. Carroll. 1995. Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity. Proc. Natl. Acad. Sci. USA 92:11490.
8. Butko, P., A. Nicholson-Weller, and M. R. Wessels. 1999. Role of complement component C1q in the IgG-independent opsonophagocytosis of group B streptococcus. J. Immunol. 163:2761.
9. Ikeda, K., T. Sannoh, N. Kawasaki, T. Kawasaki, and I. Yamashina. 1987. Serum lectin with known structure activates complement through the classical pathway. J. Biol. Chem. 262:7451.
10. Matsushita, M., Y. Endo, S. Taira, Y. Sato, T. Pujita, N. Ichikawa, M. Nakata, and T. Mizuochi. 1996. A novel human serum lectin with collagen- and fibrinogen-like domains that functions as an opsonin. J. Biol. Chem. 271:2448.
11. Sugimoto, R., Y. Yae, M. Akaiwa, S. Kitajima, Y. Shibata, H. Sato, J. Hirata, K. Okochi, K. Izuhara, and N. Hamasaki. 1998. Cloning and characterization of the Hakata antigen, a member of the ficolin/opsonin p35 lectin family. J. Biol. Chem. 273:20721.
12. Matsushita, M., M. Kuraya, N. Hamasaki, M. Tsujimura, H. Shiraki, and T. Fujita. 2002. Activation of the lectin complement pathway by H-ficolin (Hakata antigen). J. Immunol. 168:3502.
13. Matsushita, M., and T. Fujita. 2002. The role of ficolins in innate immunity. Immunobiology 205:490.
14. Matsushita, M., and T. Fujita. 1992. Activation of the classical complement pathway by mannose-binding protein in association with a novel Cls-like serine protease. J. Exp. Med. 176:1497.
15. Ji, Y. H., T. Fujita, H. Hatsuse, A. Takahashi, M. Matsushita, and M. Kawakami. 1993. Activation of the C4 and C2 components of complement by a proteinase in serum bactericidal factor, Ra reactive factor. J. Immunol. 150:571.
16. Sato, T., Y. Endo, M. Matsushita, and T. Fujita. 1994. Molecular characterization of a novel serine protease involved in activation of the complement system by mannose-binding protein. Int. Immunol. 6:665.
17. Thiel, S., T. Vorup-Jensen, C. M. Stover, W. Schwaeble, S. B. Laursen, K. Poulsen, A. C. Willis, P. Eggleton, S. Hansen, U. Holmskov, et al. 1997. A second serine protease associated with mannan-binding lectin that activates complement. Nature 386:506.
18. Matsushita, M., Y. Endo, and T. Fujita. 2000. Complement-activating complex of ficolin and mannose-binding lectin-associated serine protease. J. Immunol. 164:2281.
19. Dahl, M. R., S. Thiel, M. Matsushita, T. Fujita, A. C. Willis, T. Christensen, T. Vorup-Jensen, and J. C. Jensenius. 2001. MASP-3 and its association with distinct complexes of the mannan-binding lectin complement activation pathway. Immunity 15:127.
20. Cseh, S., L. Vera, M. Matsushita, T. Fujita, G. J. Artaud, and N. M. Thielens. 2002. Characterization of the interaction between L-ficolin/p35 and mannan-binding lectin-associated serine proteases-1 and -2. J. Immunol. 169:5735.
21. Vorup-Jensen, T., S. V. Petersen, A. G. Hansen, K. Poulsen, W. Schwaeble, R. B. Sim, K. B. Reid, S. J. Davis, S. Thiel, and J. C. Jensenius. 2000. Distinct pathway of mannan-binding lectin (MBL)-and C1-complex autoactivation revealed by reconstitution of MBL with recombinant MBL-associated serine protease-2. J. Immunol. 165:2093.
22. Rossi, V., S. Cseh, I. Bally, N. M. Thielens, J. C. Jensenius, and G. J. Artaud. 2001. Substrate specificities of recombinant mannan-binding lectin-associated serine proteases-1 and -2. J. Biol. Chem. 276:40880.
23. Shwaeble, W. J., M. R. Dahl, S. Thiel, C. M. Stover, and J. C. Jensenius. 2002. The mannan-binding lectin-associated serine proteases (MASPs) and MAp19: four components of the lectin pathway activation complex encoded by two genes. Immunobiology 205:455.
24. van Emmerik, L. C., E. J. Kuijper, C. A. Fijen, J. Dankert, and S. Thiel. 1994. Binding of mannan-binding protein to various bacterial pathogens of meningitis. Clin. Exp. Immunol. 97:411.
25. Neth, O., D. L. Jack, A. W. Dodds, H. Holzel, N. J. Klein, and M. W. Turner. 2000. Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition. Infect. Immun. 68:688.
26. Lynch, N. J., S. Roscher, T. Hartung, S. Morath, M. Matsushita, D. N. Maennel, M. Kuraya, T. Fujita, and W. J. Schwaeble. 2004. L-Ficolin specifically binds to lipoteichoic acid, a cell wall constituent of Gram-positive bacteria, and activates the lectin pathway of complement. J. Immunol. 172:1198.
27. Jennings, H. J., K.-G. Rosell, and D. L. Kasper. 1980. Structural determination and serology of the native polysaccharide antigen of type-III group B streptococcus. Can. J. Biochem. 58:112.
28. Wessels, M. R., V. Pozsgay, D. L. Kasper, and H. J. Jennings. 1987. Structure and immunochemistry of an oligosaccharide repeating unit of the capsular polysaccharide of type III group B streptococcus: a revised structure for the type III group B streptococcal polysaccharide antigen. J. Biol. Chem. 262:8262.
29. Cieslewicz, M. J., D. L. Kasper, Y. Wang, and M. R. Wessels. 2001. Functional analysis in type la group B streptococcus of a cluster of genes involved in extracellular polysaccharide production by diverse species of streptococci. J. Biol. Chem. 276:139.
30. Adderson, E. E., S. Takahashi, Y. Wang, J. Armstrong, D. V. Miller, and J. F. Bohnsack. 2003. Subtractive hybridization identifies a novel predicted protein mediating epithelial cell invasion by virulent serotype III group B Streptococcus agalactiae. Infect. Immun. 71:6857.
31. Jennings, H. J., E. Katzenellenbogen, C. Lugowski, and D. L. Kasper. 1983. Structure of negative polysaccharide antigens of type Ia and type Ib group B streptococcus. Biochemistry 22:7258.
32. Ouchterlony, O. 1962. Diffusion-in-gel methods for immunological analysis. II. Prog. Allergy 6:30.
33. Aminoff, D. 1961. Methods for the quantitative estimation of N-acetylneuraminic acid and their application to hydrolysates of sialomucoids. Biochem. J. 81:384.
34. Tenner, A. J., P. H. Lesavre, and N. R. Cooper. 1981. Purification and radiolabeling of human C1q. J. Immunol. 127:648.
35. Takahashi, S., Y. Nagano, N. Nagano, O. Hayashi, F. Taguchi, and Y. Okuwaki. 1995. Role of C5a-ase in group B streptococcal resistance to opsonophagocytic killing. Infect. Immun. 63:4764.
36. Petersen, S. V., S. Thiel, L. Jensen, R. Steffensen, and J. C. Jensenius. 2001. An assay for the mannan-binding lectin pathway of complement activation. J. Immunol. Methods 257:107.
37. Suankratay, C., X.-H. Zhang, Y. Zhang, T. F. Lint, and H. Gewurz. 1998. Requirement for the alternative pathway as well as C4 and C2 in complement-dependent hemolysis via the lectin pathway. J. Immunol. 160:3006.
38. Neth, O., D. L. Jack, M. Johnson, N. J. Klein, and M. W. Turner. 2002. Enhancement of complement activation and opsonophagocytosis by complexes of mannose-binding lectin with mannose-binding lectin-associated serine protease after binding to Staphylococcus aureus. J. Immunol. 169:4430.
39. Le, Y., S. H. Lee, O. L. Kon, and J. Lu. 1998. Humanibo L-fikolin: plasma levels, sugar specificity, and assignment of its lectin activity to the fibrinogen-like (FBG) domain. FEBS Lett. 425:367.
40. Fearon, D. T. 1978. Regulation by membrane stalk acid of β1H-dependent decay-dissociation of amplification C3 convertase of the alternative complement pathway. Proc. Natl. Acad. Sci. USA 75:1971.
41. Pangburn, M. K., and H. J. Müller-Eberhard. 1978. Complement C3 convertase: cell surface restriction of β1H control and generation of restriction on neuraminidase-treated cells. Proc. Natl. Acad. Sci. USA 75:2416.
42. Marques, M. B., D. L. Kasper, M. K. Pangburn, and M. R. Wessels. 1992. Prevention of C3 deposition by capsular polysaccharide is a virulence mechanism of type III group B streptococci. Infect. Immun. 60:3986.
43. Wessels, M. R., R. F. Haft, L. M. Heggen, and C. E. Rubens. 1992. Identification of a genetic locus essential for capsule sialylation in type III group B streptococci. Infect. Immun. 60:392.
44. Stålhammar-Carlemalm, M., L. Stenberg, and G. Lindahl. 1993. Protein Rib: a novel group B streptococcal cell surface protein that confers protective immunity and is expressed by most strains causing invasive infections. J. Exp. Med. 177:1593.
45. Musser, J. M., S. J. Mattingly, R. Quentin, A. Goudeau, and R. K. Selander. 1989. Identification of a high-virulence clone of type III Streptococcus agalactiae (group B streptococcus) causing invasive neonatal disease. Proc. Natl. Acad. Sci. USA 86:4731.
46. Nagano, Y., N. Nagano, S. Takahashi, K. Murono, K. Fujita, F. Taguchi, and Y. Okuwaki. 1991. Restriction endonuclease digest patterns of chromosomal DNA from group B β-haemolitic streptococci. J. Med. Microbiol. 35:297.
47. Takahashi, S., E. E. Adderson, Y. Nagano, N. Nagano, M. R. Briesacher, and J. F. Bohnsack. 1998. Identification of a highly encapsulated, genetically related group of invasive type III group B streptococci. J. Infect. Dis. 177:1116.
48. Takahashi, S., S. Detrick, A. Whiting, A. Blascheke-Bonkowksy, Y. Aoyagi, E. Adderson, and J. Bohnsack. 2002. Correlation of phylogenetic lineages of group B streptococci, identified by analysis of restriction digest patterns of genomic DNA, with infB alleles and mobile genetic elements. J. Infect. Dis. 186:1034.
49. Jennings, H. J., K.-G. Resell, E. Katzenellenbogen, and D. L. Kasper. 1983. Structural determination of the capsular polysaccharide antigen of type II group B streptococcus. J. Biol. Chem. 258:1793.
50. Wessels, M. R., W. J. Benedi, H. Jennings, F. Michon, J. L. DiFabio, and D. L. Kasper. 1989. Isolation and characterization of type IV group B streptococcus capsular polysaccharide. Infect. Immun. 57:1089.
51. Wessels, M. R., J. L. DiFabio, V. J. Benedi, D. L. Kasper, F. Michon, J. R. Brisson, J. Jelinkova, and H. J. Jennings. 1991. Structural determination and immunochemical characterization of the type V group B streptococcus capsular polysaccharide. J. Biol. Chem. 266:6714.
52. Kogan, G., J. R. Brisson, D. L. Kasper, C. von Hunolstein, G. Orefici, and H. J. Jennings. 1995. Structural elucidation of the novel type VII group B streptococcus capsular polysaccharide by high resolution NMR spectroscopy. Carbohydr. Res. 277:1.
53. von Hunolstein, C., S. D'ascenzi, B. Wagner, J. Jelinkova, G. Alfarone, S. Recchia, M. Wagner, and G. Orefici. 1993. Immunochemistry of capsular type polysaccharide and virulence properties of type VI Streptococcus agalactiae (group B streptococci). Infect. Immun. 61:1272.
54. Kogan, G., D. Uhrín, J.-R. Brisson, L. C. Paoletti, A. E. Blodgett, D. L. Kasper, and H. J. Jennings. 1996. Structural and immunochemical characterization of the type VIII group B streptococcus capsular polysaccharide. J. Biol. Chem. 271:8786.